The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.

[1]  S. Rutz,et al.  IL‐22, not simply a Th17 cytokine , 2013, Immunological reviews.

[2]  J. Renauld,et al.  IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect , 2013, Leukemia.

[3]  R. Jenq,et al.  Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. , 2012, Immunity.

[4]  J. Moorman,et al.  Tim-3 Pathway Controls Regulatory and Effector T Cell Balance during Hepatitis C Virus Infection , 2012, The Journal of Immunology.

[5]  Kailin Xu,et al.  CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. , 2012, Immunology letters.

[6]  R. Jenq,et al.  Interleukin-22 Drives Endogenous Thymic Regeneration in Mice , 2012, Science.

[7]  Kailin Xu,et al.  Altered balance between Th1 and Th17 cells in circulation is an indicator for the severity of murine acute GVHD. , 2012, Immunology letters.

[8]  Kailin Xu,et al.  Effects of High-Dose Dexamethasone on Regulating Interleukin-22 Production and Correcting Th1 and Th22 Polarization in Immune Thrombocytopenia , 2012, Journal of Clinical Immunology.

[9]  R. Levy.  Repertoire isn't everything for GVHD. , 2011, Blood.

[10]  Kailin Xu,et al.  Elevated plasma IL-22 levels correlated with Th1 and Th22 cells in patients with immune thrombocytopenia. , 2011, Clinical immunology.

[11]  D. Artis,et al.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.

[12]  L. Li,et al.  ESAT‐6‐ and CFP‐10‐Specific Th1, Th22 and Th17 Cells in Tuberculous Pleurisy May Contribute to the Local Immune Response Against Mycobacterium Tuberculosis Infection , 2011, Scandinavian journal of immunology.

[13]  M. Shlomchik,et al.  A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. , 2011, Blood.

[14]  W. Paul,et al.  Peripheral CD4+ T‐cell differentiation regulated by networks of cytokines and transcription factors , 2010, Immunological reviews.

[15]  R. Sabat,et al.  Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. , 2010, Cytokine & growth factor reviews.

[16]  A. Blauvelt,et al.  Circulating Th17, Th22, and Th1 cells are increased in psoriasis. , 2010, The Journal of investigative dermatology.

[17]  R. Sabat,et al.  Biology of interleukin-22 , 2010, Seminars in Immunopathology.

[18]  S. Durham,et al.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.

[19]  E. Waller,et al.  Dichotomous role of interferon-gamma in allogeneic bone marrow transplant. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  Hulun Li,et al.  Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis , 2009, Immunology.

[21]  H. Spits,et al.  Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells , 2009, Nature Immunology.

[22]  D. Jarrossay,et al.  Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells , 2009, Nature Immunology.

[23]  Changyou Wu,et al.  Memory IL‐22‐producing CD4+ T cells specific for Candida albicans are present in humans , 2009, European journal of immunology.

[24]  Michelle L. West,et al.  In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. , 2009, Blood.

[25]  Christopher G. King,et al.  IL-17 contributes to CD4-mediated graft-versus-host disease. , 2009, Blood.

[26]  T. Yi,et al.  Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. , 2008, Blood.

[27]  D. Jain,et al.  Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. , 2008, Blood.

[28]  L. Fouser,et al.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. , 2008, The Journal of clinical investigation.

[29]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[30]  F. Morel,et al.  A role for T cell‐derived interleukin 22 in psoriatic skin inflammation , 2007, Clinical and experimental immunology.

[31]  P. Reddy,et al.  Pathophysiology of acute graft-versus-host disease: recent advances. , 2007, Translational research : the journal of laboratory and clinical medicine.

[32]  R. Sabat,et al.  Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. , 2006, Cytokine & growth factor reviews.

[33]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[34]  C. D. Krause,et al.  Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.

[35]  J. Renauld,et al.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Sykes,et al.  Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. , 1998, The Journal of clinical investigation.